NCT00240708View on ClinicalTrials.gov

A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

April 30, 2006

Conditions
Schizophrenia
Interventions
DRUG

risperidone

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY